FDA Questions J&J/Merck OTC Joint Venture's Manufacturing Practices
This article was originally published in The Tan Sheet
Executive Summary
Johnson & Johnson and Merck attract undesired FDA attention - a letter identifying good manufacturing practice problems with the firms' OTC joint venture